标题
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-19
DOI
10.1038/s41467-020-20723-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
- (2019) Chao Lin et al. GUT
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency
- (2019) Qingle Liang et al. Nature Biomedical Engineering
- Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
- (2019) Ji-Chang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
- (2019) Mónica Pascual-García et al. Nature Communications
- CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
- (2019) Luigi Racioppi et al. Nature Communications
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells
- (2018) A. Le Moignic et al. JOURNAL OF CONTROLLED RELEASE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma
- (2018) Irene Soncin et al. Nature Communications
- Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment
- (2018) Daria S. Chulpanova et al. Frontiers in Immunology
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors
- (2018) Yeon Woong Choo et al. ACS Nano
- Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
- (2018) Simon R. Lord et al. Cell Metabolism
- Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
- (2018) Jeffrey Yang et al. MEDICINAL RESEARCH REVIEWS
- Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
- (2018) Keaton I Jones et al. EMBO Molecular Medicine
- Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
- (2018) Jinfang Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- (2017) Amir Sonnenblick et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
- (2017) Lifang Cheng et al. MOLECULAR THERAPY
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
- (2017) Chi-Fu Chiang et al. Oncotarget
- Extracellular vesicles for drug delivery
- (2016) Pieter Vader et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- A Breakthrough: Macrophage-Directed Cancer Immunotherapy
- (2016) C. D. Mills et al. CANCER RESEARCH
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles
- (2016) Jingwei Ma et al. CELL RESEARCH
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Drug delivery to macrophages: Challenges and opportunities
- (2016) Yihua Pei et al. JOURNAL OF CONTROLLED RELEASE
- Metformin: An anti-diabetic drug to fight cancer
- (2016) Marie Daugan et al. PHARMACOLOGICAL RESEARCH
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Learning from PD-1 Resistance: New Combination Strategies
- (2016) Xia Bu et al. TRENDS IN MOLECULAR MEDICINE
- A novel platform for cancer therapy using extracellular vesicles
- (2015) Naoomi Tominaga et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
- (2015) Roy L. Maute et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
- (2015) Ling Ding et al. Oncotarget
- Transformation of Cell-Derived Microparticles into Quantum-Dot-Labeled Nanovectors for Antitumor siRNA Delivery
- (2014) Gang Chen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
- (2012) Ke Tang et al. Nature Communications
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters
- (2011) Gregory M Palmer et al. Nature Protocols
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started